1. Home
  2. LFVN vs AVR Comparison

LFVN vs AVR Comparison

Compare LFVN & AVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LFVN
  • AVR
  • Stock Information
  • Founded
  • LFVN N/A
  • AVR 1999
  • Country
  • LFVN United States
  • AVR Australia
  • Employees
  • LFVN N/A
  • AVR N/A
  • Industry
  • LFVN Biotechnology: Pharmaceutical Preparations
  • AVR
  • Sector
  • LFVN Health Care
  • AVR
  • Exchange
  • LFVN Nasdaq
  • AVR NYSE
  • Market Cap
  • LFVN 206.0M
  • AVR 215.6M
  • IPO Year
  • LFVN N/A
  • AVR 2024
  • Fundamental
  • Price
  • LFVN $25.31
  • AVR $5.99
  • Analyst Decision
  • LFVN Strong Buy
  • AVR Strong Buy
  • Analyst Count
  • LFVN 2
  • AVR 4
  • Target Price
  • LFVN $30.50
  • AVR $16.50
  • AVG Volume (30 Days)
  • LFVN 185.6K
  • AVR 158.4K
  • Earning Date
  • LFVN 01-28-2025
  • AVR 01-01-0001
  • Dividend Yield
  • LFVN 0.63%
  • AVR N/A
  • EPS Growth
  • LFVN 59.77
  • AVR N/A
  • EPS
  • LFVN 0.32
  • AVR N/A
  • Revenue
  • LFVN $196,014,000.00
  • AVR $2,826,588.00
  • Revenue This Year
  • LFVN $4.11
  • AVR N/A
  • Revenue Next Year
  • LFVN $4.08
  • AVR N/A
  • P/E Ratio
  • LFVN $79.21
  • AVR N/A
  • Revenue Growth
  • LFVN N/A
  • AVR N/A
  • 52 Week Low
  • LFVN $5.22
  • AVR $5.10
  • 52 Week High
  • LFVN $27.38
  • AVR $6.10
  • Technical
  • Relative Strength Index (RSI)
  • LFVN 74.94
  • AVR N/A
  • Support Level
  • LFVN $15.99
  • AVR N/A
  • Resistance Level
  • LFVN $27.38
  • AVR N/A
  • Average True Range (ATR)
  • LFVN 1.80
  • AVR 0.00
  • MACD
  • LFVN 0.71
  • AVR 0.00
  • Stochastic Oscillator
  • LFVN 81.82
  • AVR 0.00

About LFVN Lifevantage Corporation (Delaware)

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

About AVR ANTERIS TECHNOLOGIES GLOBAL CORP

Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.

Share on Social Networks: